Literature DB >> 1504420

Diagnosis and management of endobronchial tuberculosis.

T Kurasawa1, F Kuze, M Kawai, R Amitani, T Murayama, E Tanaka, K Suzuki, Y Kubo, Y Matsui, A Sato.   

Abstract

We examined the records of sixty-one patients (17 males and 44 females) with endobronchial tuberculosis (EBTB). Smear tests of acid-fast bacilli were positive in 42 cases and cultures of tubercle bacilli (TB) were positive in 57. The main findings of chest roentgenogram on admission were as follows: no abnormal findings in 8, atelectasis in 30, infiltration in 25, and cavitary lesions in 6. The localization and cross-sectional extension of lesions confirmed bronchoscopically were as follows: trachea in 15, with 3 circular lesions (CLs). Right (R-) main bronchus in 19 with 11 CLs, left (L-) main bronchus in 18 with 11 of CLs, R-truncus intermedius in 14 with 6 of CLs, R-upper lobar bronchus (UB) in 17 with 12 CLs, R-middle lobar bronchus in 14 with 11 of CLs, R-lower lobar bronchus (LB) in 6 with 2 CLs, L-UB in 10 with 7 CLs and L-LB in 3 with 2 CLs. All cases were treated by combination chemotherapy with isoniazid, rifampicin, streptomycin and/or ethambutol and the rate of negative conversion of TB was good, but most of circular lesions resulted in severe bronchial stenosis or complete obstruction during and after chemotherapy, and no improvement was seen in any of the atelectasis cases at the cessation of chemotherapy. We discuss the points of early diagnosis and management of EBTB.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1504420     DOI: 10.2169/internalmedicine.31.593

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

Review 1.  Tracheobronchial tuberculosis.

Authors:  Vikas Pathak; Ray W Shepherd; Samira Shojaee
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 2.  Endobronchial tuberculosis-a review.

Authors:  Talha Shahzad; Muhammad Irfan
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  Characteristics of endobronchial tuberculosis patients with negative sputum acid-fast bacillus.

Authors:  Füsun Sahin; Pınar Yıldız
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

4.  Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis.

Authors:  Sung-Soo Jung; Hee-Sun Park; Ju-Ock Kim; Sun-Young Kim
Journal:  Respirology       Date:  2015-01-26       Impact factor: 6.424

5.  Treatment of multiple-level tracheobronchial stenosis secondary to endobronchial tuberculosis using bronchoscopic balloon dilatation with topical mitomycin-C.

Authors:  Mohamed Faisal; Hafaruzi Harun; Tidi M Hassan; Andrea Y L Ban; Sanjay H Chotirmall; Jamalul Azizi Abdul Rahaman
Journal:  BMC Pulm Med       Date:  2016-04-14       Impact factor: 3.317

6.  Bronchoscopic Features and Morphology of Endobronchial Tuberculosis: A Malaysian Tertiary Hospital Experience.

Authors:  Nurul Yaqeen Mohd Esa; Siti Kamariah Othman; Mohd Arif Mohd Zim; Tengku Saifudin Tengku Ismail; Ahmad Izuanuddin Ismail
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

7.  Endobronchial tuberculosis: histopathological subsets and microbiological results.

Authors:  Sevket Ozkaya; Salih Bilgin; Serhat Findik; Hayriye Cete Kök; Canan Yuksel; Atilla Güven Atıcı
Journal:  Multidiscip Respir Med       Date:  2012-10-22

8.  Endobronchial Tubercolosis: a peculiar feature of TB often underdiagnosed.

Authors:  Lucio Casali; Mariano E Crapa
Journal:  Multidiscip Respir Med       Date:  2012-10-22

9.  Mechanical complication of endobronchial tuberculosis.

Authors:  Quratulain Fatima Kizilbash
Journal:  Respir Med Case Rep       Date:  2015-09-21

10.  Self-expanding covered metallic stents as a transition to silicone stent implantation in management of severe post-tuberculosis bronchial stenosis.

Authors:  Zi-Qing Zhou; Jia-Xin Feng; Yu Chen; Zhu-Quan Su; Chang-Hao Zhong; Xiao-Bo Chen; Chun-Li Tang; Jie-Rong Huang; Shi-Yue Li
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.